Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/7/2023 | Outperform | William Blair |
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about
WESTFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) reported its financial results for the fourth quarter and fiscal year ended December 28, 2024. Fourth Quarter Financial Highlights Revenue increased 8% to $258 millionGross margin was 43.4%Net income decreased 12% to $24 millionGAAP EPS decreased 12% to $2.04Adjusted EPS decreased 7% to $2.25Adjusted EBITDA increased 8% to $52 million and represented 20.3% of revenueOperating cash flow decreased 12% to $52 millionBookings increased 10% to $241 million Fiscal Year Financial Highlights Revenue increased 10% to a record $1.05 billionGross margin was 44.3%Net income decreased 4% to $112 millionGAAP EPS decreased 4% t
William Blair resumed coverage of Kadant with a rating of Outperform
Barrington Research reiterated coverage of Kadant with a rating of Outperform and set a new price target of $200.00 from $190.00 previously
Barrington Research reiterated coverage of Kadant with a rating of Outperform and set a new price target of $190.00 from $175.00 previously
8-K - KADANT INC (0000886346) (Filer)
SCHEDULE 13G/A - KADANT INC (0000886346) (Subject)
SCHEDULE 13G/A - KADANT INC (0000886346) (Subject)
WESTFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) reported its financial results for the fourth quarter and fiscal year ended December 28, 2024. Fourth Quarter Financial Highlights Revenue increased 8% to $258 millionGross margin was 43.4%Net income decreased 12% to $24 millionGAAP EPS decreased 12% to $2.04Adjusted EPS decreased 7% to $2.25Adjusted EBITDA increased 8% to $52 million and represented 20.3% of revenueOperating cash flow decreased 12% to $52 millionBookings increased 10% to $241 million Fiscal Year Financial Highlights Revenue increased 10% to a record $1.05 billionGross margin was 44.3%Net income decreased 4% to $112 millionGAAP EPS decreased 4% t
WESTFORD, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) announced it will release its 2024 fourth quarter and full-year results after the market closes on Wednesday, February 12, 2025 and will hold a webcast the next day, Thursday, February 13, 2025 at 11:00 a.m. Eastern Standard Time. During the call the Company will discuss its fourth quarter and full-year financial performance and future expectations. To listen to the live call and view the webcast, go to the "Investors" section of the Company's website at kadant.com. Participants interested in joining the call's live question and answer session are required to register by clicking here or selecting the Q&A link on ou
WESTFORD, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.32 per share to be paid on February 6, 2025 to stockholders of record as of the close of business on January 9, 2025. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change. About Kadant Kadant Inc. is a global supplier of technologies and engineered systems that drive Sustainable Industrial Processing®. The Company's products and services play an integral role in enhancing efficiency, optimizing energy utilization, and maximizing
4 - KADANT INC (0000886346) (Issuer)
4 - KADANT INC (0000886346) (Issuer)
4 - KADANT INC (0000886346) (Issuer)
SC 13G/A - KADANT INC (0000886346) (Subject)
SC 13G/A - KADANT INC (0000886346) (Subject)
SC 13G/A - KADANT INC (0000886346) (Subject)
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about
WESTFORD, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI), a global supplier of technologies and engineered systems, today announced the expansion of the board of directors from six to seven directors and the appointment of Rebecca Martinez O'Mara to its board of directors effective May 1, 2022. Ms. O'Mara was appointed to the class of directors the term for which expires at Kadant's 2024 annual meeting of stockholders. Ms. O'Mara served as the president of industrial services for Stanley Black & Decker, Inc., a Fortune 500 manufacturer of industrial tools and household hardware. She was previously vice president of services and solutions at Grundfos Holdings A/S, a globa